AI
Saturday, October 29, 2011 12:32:57 AM
Don't hate the player, hate the game. Besides, the market is wide open for an unlimited amount of competitors. All they have to do is come up with their own unique way of proving sameness of their drug like MNTA did, and not infringe on another's patents like Amphastar did
. BTW, the balloon is being re-inflated. Too bad you sold into the strength below $12. Looks like that was the wrong move. What's your next move? Buy some TEVA?
(As usual, all forward looking statements are my opinion only.)
Have a great day everyone!
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
